Carolyn Graber

1PUBLICATIONS
2CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Aug 07, 2021
Rationale for a Combination Therapy with the STAT5 Inhibitor AC-4-130 and the MCL1 Inhibitor S63845 in the Treatment of FLT3-Mutated or TET2-Mutated Acute Myeloid Leukemia.

Katja Seipel, Carolyn Graber, Laura Flückiger

Pageof 1

Frequent Collaborators

1 joint publications

Katja Seipel

1 joint publications

Ulrike Bacher